reboxetine has been researched along with s,n,n'-tripropylthiocarbamate in 5 studies
| Studies (reboxetine) | Trials (reboxetine) | Recent Studies (post-2010) (reboxetine) | Studies (s,n,n'-tripropylthiocarbamate) | Trials (s,n,n'-tripropylthiocarbamate) | Recent Studies (post-2010) (s,n,n'-tripropylthiocarbamate) |
|---|---|---|---|---|---|
| 626 | 193 | 184 | 25,982 | 1,226 | 16,193 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abumaria, N; Flügge, G; Fuchs, E; Havemann-Reinecke, U; Hiemke, C; Rüther, E; Rygula, R; Zernig, G | 1 |
| Cowen, PJ; Harmer, CJ; McCabe, C; Mishor, Z | 1 |
| Conrad, KL; Davis, AR; Javitch, JA; Lindsley, CW; Matthies, HJ; Saleh, SA; Sen, N; Sheffler, DJ; Shields, AD; Silberman, Y; Winder, DG | 1 |
| Anderson, MH; Munafò, MR; Robinson, ES | 1 |
| Cui, R; Li, X; Liu, L; Ruan, H; Wang, L | 1 |
1 trial(s) available for reboxetine and s,n,n'-tripropylthiocarbamate
| Article | Year |
|---|---|
Diminished neural processing of aversive and rewarding stimuli during selective serotonin reuptake inhibitor treatment.
Topics: Adrenergic Uptake Inhibitors; Adult; Affect; Anxiety Disorders; Citalopram; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Morpholines; Nerve Net; Reboxetine; Reward; Selective Serotonin Reuptake Inhibitors; Young Adult | 2010 |
4 other study(ies) available for reboxetine and s,n,n'-tripropylthiocarbamate
| Article | Year |
|---|---|
Pharmacological validation of a chronic social stress model of depression in rats: effects of reboxetine, haloperidol and diazepam.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Behavior, Animal; Depression; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug; Haloperidol; Male; Morpholines; Motivation; Motor Activity; Rats; Rats, Wistar; Reboxetine; Reward; Stress, Psychological | 2008 |
Yohimbine depresses excitatory transmission in BNST and impairs extinction of cocaine place preference through orexin-dependent, norepinephrine-independent processes.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Antagonists; Animals; Behavior, Animal; Cocaine; Drug-Seeking Behavior; Extinction, Psychological; Intracellular Signaling Peptides and Proteins; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Morpholines; Neuropeptides; Neurotransmitter Agents; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Orexin Receptors; Orexins; Patch-Clamp Techniques; Reboxetine; Receptors, Adrenergic, alpha-2; Receptors, Corticotropin-Releasing Hormone; Receptors, Neuropeptide; Reward; Septal Nuclei; Synaptic Transmission; Yohimbine | 2012 |
Investigating the psychopharmacology of cognitive affective bias in rats using an affective tone discrimination task.
Topics: Affect; Animals; Anti-Anxiety Agents; Antidepressive Agents; Bias; Cognition; Cues; Diazepam; Discrimination Learning; Dose-Response Relationship, Drug; Drug Administration Schedule; Fluoxetine; Male; Morpholines; Rats; Reboxetine; Reward | 2013 |
Effects of noradrenergic and serotonergic systems on risk-based decision-making and center arena activity in open field in rats.
Topics: Animals; Behavior, Animal; Choice Behavior; Citalopram; Decision Making; Dexmedetomidine; Male; Norepinephrine; Rats; Rats, Sprague-Dawley; Reboxetine; Reward; Risk-Taking; Serotonin | 2018 |